CompletedNot Applicable

PVAC GOLD Versus Irrigated RF Single Tip Catheter With Contact FORCE Ablation of the Pulmonary Veins for Treatment of Drug Refractory Symptomatic Paroxysmal and Persistent Atrial Fibrillation

Germany, Netherlands212 participantsStarted 2015-06

Plain-language summary

The GOLD FORCE trial investigates the differences between treatment with a Contact Force single-tip catheter against the PVAC GOLD multielectrode catheter in cardiac ablation procedures in patients with paroxysmal atrial fibrillation.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. History of symptomatic paroxysmal atrial fibrillation defined as:
✓. Age between 18 and 70 Willingness, ability and commitment to participate in baseline and follow-up evaluations for the full length of the study

Exclusion criteria

✕. Structural heart disease of clinical significance including:
✕. Prior ablation for arrhythmias other than AF within the past three months
✕. Prior left sided AF ablation
✕. Enrollment in any other ongoing arrhythmia study protocol Any ventricular tachy-arrhythmias currently being treated where the arrhythmia or the management may interfere with this study

What they're measuring

Number of participants free of Atrial Fibrillation and not taking anti-arrhythmic drugs

Timeframe: Month 3 after intervention

Trial details

NCT IDNCT02463851

SponsorL.V.A. Boersma

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-04-01

View on ClinicalTrials.gov More Atrial Fibrillation trials